Targeted Clinical Trials for Antimicrobial Resistance
$1,730,876N01FY2012AINIH
Duke University, Durham NC
Investigators
Abstract
To evaluate strategies that test the safety and effectiveness of therapeutic approaches/regimens to reduce the probability of the emergence of antibiotic drug resistance by minimizing unnecessary drug exposure.
View original record on NIH RePORTER →